VERICEL CORPORATION Cash
VERICEL CORPORATION (VCEL) had Cash of $35.08 million as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2019-05-07
- 2019-03-31: Cash $35.08M.
- 2018-12-31: Cash $18.29M.
- 2018-09-30: Cash $53.29M.
- 2018-06-30: Cash $94.97M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2019-03-31 | $35.08M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $18.29M 10-Q · filed 2019-05-07 | |
| 2018-09-30 | $53.29M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $94.97M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $29.78M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $26.86M 10-Q · filed 2019-05-07 | |
| 2017-09-30 | $15.47M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $14.04M 10-Q · filed 2018-08-06 | |
| 2017-03-31 | $19.85M 10-Q · filed 2018-05-08 | |
| 2016-12-31 | $22.98M 10-K · filed 2019-02-26 | |
| 2016-09-30 | $8.88M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $9.84M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $13.54M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $14.58M 10-K · filed 2019-02-26 | |
| 2015-09-30 | $18.72M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $20.22M 10-Q · filed 2016-08-08 | |
| 2015-03-31 | $25.90M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $30.34M 10-K · filed 2018-03-05 | |
| 2014-09-30 | $37.58M 10-Q · filed 2015-11-13 | |
| 2014-06-30 | $7.26M 10-Q · filed 2015-08-12 | |
| 2014-03-31 | $25.90M 10-Q · filed 2016-05-10 | $8.84M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $8.06M 10-K · filed 2017-03-13 | |
| 2013-09-30 | $10.82M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $4.49M 10-Q · filed 2014-08-14 | |
| 2013-03-31 | $9.23M 10-Q · filed 2014-05-15 | |
| 2012-12-31 | $13.64M 10-K · filed 2016-03-14 | |
| 2011-12-31 | $5.53M 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |